Trial for CAR T-cell Therapy in Ovarian, Other Cancers to Begin
Fresh Trial for Celyad’s CAR T-cell Therapy in Ovarian, Other Cancers to Begin in Belgium Celyad’s fresh trial evaluating the effectiveness and safety of its drug candidate NKR-2 (a CAR …Read more